02 Ingredient sourcing
Ergothioneine
L-ergothioneine
Ergothioneine is a fast-growing ingredient in longevity and healthy-ageing formulas. Few factories make it well. We find manufacturers that can prove purity and origin, check the paperwork in Chinese, and secure reliable supply.
- Form covered
- Fermentation-derived L-ergothioneine, high-purity powder
Why brands source it
L-ergothioneine is offered to brands as a purified ingredient made either by chemical synthesis or by microbial fermentation. Regulators have assessed both routes separately, which is why the route has to be documented [1][2][3].
In the EU, synthetic L-ergothioneine was authorised as a novel food after an EFSA safety opinion [1][2]. In the US, FDA has issued “no questions” letters on GRAS notices for L-ergothioneine, including GRN 1270, which covers material produced by an engineered Escherichia coli strain [3].
Because the ingredient is a defined compound, a brand can and should hold a supplier to a tight specification. That makes the documents easier to audit, and gaps easier to see.
Where it is used
Capsules
Single-ingredient L-ergothioneine products, typically in the 5 to 30 mg range per serving.
Longevity stacks
Combined with NAD+ precursors, mushroom extracts or other antioxidants in healthy-ageing formulas.
Mushroom-based formulas
Positioned alongside mushroom extracts, since ergothioneine occurs naturally in mushrooms.
Skincare and beauty-from-within
Used in nutricosmetic and topical products.
Well-known products that contain it
- Life Extension Mega L-Ergothioneine
- Real Mushrooms Ergo+
- Double Wood Supplements L-Ergothioneine
Listed as market examples. Brand names belong to their owners.
What usually goes wrong
- 01
Purity without a chromatogram
A purity figure “by HPLC” with no chromatogram, no method summary and no reference standard cannot be checked. We ask for the trace, the integration, the column and conditions, and the source of the reference standard.
- 02
“Fermented” with no organism or process record
Fermentation claims need a named production organism and strain, a process outline and the downstream purification steps. Where the organism is genetically engineered, the documentation should say so, because some markets and some labels treat that differently.
- 03
Solvents and impurities not reported
Purification and crystallisation often use solvents. Residual solvents should be reported against a recognised framework such as ICH Q3C [4], with individual named impurities rather than “total impurities” alone.
- 04
Stability claims without stability data
Shelf life should be backed by a stability study under defined conditions [5], not a default “24 months” on the COA.
- 05
One producer, no contingency
Supply of high-purity ergothioneine may depend on a small number of producers. A single qualified source is a business risk as much as a quality one.
What we check
Typical specification areas and the test methods we expect to see. Numeric targets are set per brief, against your specification and your markets.
| Specification area | Test method | What we look for |
|---|---|---|
| Assay and purity | HPLC with chromatogram, method summary and reference standard | Purity minimum set to your specification. Named impurities reported individually. |
| Identity | HPLC retention against reference, plus a second technique such as IR or MS | Identity by two orthogonal methods where the supplier can provide them. |
| Origin documentation | Production organism and strain, process flow, GMO status statement | Fermented versus synthetic route stated and evidenced, not only claimed. |
| Residual solvents | Headspace GC, reported against ICH Q3C classes [4] | Every solvent used in the process named on the flow chart. |
| Heavy metals | ICP-MS with numeric results [6] | Limits matched to the markets you sell into. |
| Microbiology | Total aerobic count, yeast and mould, specified pathogens [7] | Particularly relevant for fermentation-derived material. |
| Stability | Real-time and accelerated stability data [5] | Supports the retest or expiry date printed on the COA. |
| Laboratory | ISO/IEC 17025 accreditation, scope checked per test [10] | Independent lab confirmation on at least one production lot. |
Documents we request
- Lot-specific COA with HPLC chromatogram and method summary
- Specification sheet naming the method for every parameter
- Process flow chart from fermentation (or synthesis) to final powder, with all solvents and reagents
- Production organism and strain statement, and GMO status declaration
- Residual solvent and elemental impurity statement
- Stability study summary supporting the retest or expiry date
- Regulatory documents the supplier relies on (GRAS notice, novel food authorisation, NDI correspondence), for your counsel to review
- Statement on patents or licences covering the process or the product, for your counsel to review
Red flags
- Purity stated with no chromatogram or reference standard
- “Fermented” on the COA with no organism, strain or process record
- Total impurities only, no individual named impurities
- No residual solvent data despite solvent use in purification
- Expiry date with no stability study behind it
- Supplier cites another company’s GRAS notice or authorisation as if it were its own
- Supplier unwilling to discuss the patent or licence position of its process
Sourcing notes
Ergothioneine is an ingredient where the regulatory and commercial questions arrive before the quality ones. Settle them early, with the right people.
- Regulatory status is market-specific. An EU novel food authorisation, a US GRAS “no questions” letter and a US new dietary ingredient notification are different instruments with different scopes [2, 3, 8]. Which of them covers your product, in your form and at your dose, is a question for qualified regulatory counsel. We collect the supplier’s documents so your counsel can answer it.
- Patents can attach to the process or the use. Before launch, ask the supplier in writing whether its process is patented or licensed, and by whom. Your counsel can review the position; public databases such as Espacenet are a starting point, not an answer [9].
- Plan for a second source. If only one producer can meet your specification today, qualify a second one before you scale, or at least agree change-notification and allocation terms in writing.
What we can do is make sure the technical file is complete and internally consistent, and that the material on the pallet is the material described in that file.
Sources
- [1] EFSA Panel on Dietetic Products, Nutrition and Allergies. Safety of synthetic L-ergothioneine (Ergoneine®) as a novel food pursuant to Regulation (EC) No 258/97. EFSA Journal. 2016;14(11):4629. doi:10.2903/j.efsa.2016.4629. efsa.onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4629
- [2] Commission Implementing Decision (EU) 2017/1281 authorising the placing on the market of L-ergothioneine as a novel food ingredient under Regulation (EC) No 258/97. eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:32017D1281
- [3] US Food and Drug Administration. GRAS Notice No. 1270, L-ergothioneine produced by Escherichia coli K-12 MG1655 expressing enzymes from Neurospora crassa and Mycolicibacterium smegmatis. Closed 22 January 2026, FDA has no questions. The response letter also refers to earlier ergothioneine notices answered in 2018 and 2025. www.hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=1270
- [4] International Council for Harmonisation. ICH Q3C, Impurities. Guideline for residual solvents. www.ich.org/page/quality-guidelines
- [5] International Council for Harmonisation. ICH Q1A(R2), Stability testing of new drug substances and products. www.ich.org/page/quality-guidelines
- [6] United States Pharmacopeia. General Chapter 2232, Elemental contaminants in dietary supplements.
- [7] United States Pharmacopeia. General Chapters 2021 and 2022, Microbial enumeration tests and microbiological procedures for absence of specified microorganisms, nutritional and dietary supplements.
- [8] US Food and Drug Administration. New Dietary Ingredient (NDI) Notification Process. www.fda.gov/food/dietary-supplements/new-dietary-ingredient-ndi-notification-process
- [9] European Patent Office. Espacenet patent search. worldwide.espacenet.com/
- [10] ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. International Organization for Standardization. www.iso.org/standard/66912.html
Next step
Need a reliable Ergothioneine supplier?
Tell us your target quality and volumes. We reply within two working days with a sourcing plan and a fixed quote.